70 related articles for article (PubMed ID: 30362626)
1. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X
Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma.
Sheng JQ; Wang MR; Fang D; Liu L; Huang WJ; Tian DA; He XX; Li PY
Biomed Pharmacother; 2021 Jan; 133():111023. PubMed ID: 33378941
[TBL] [Abstract][Full Text] [Related]
3. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
[TBL] [Abstract][Full Text] [Related]
4. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
Chang L; Wang J; Zhou F; Wang D; Chen R; Zhang Y; Zhang J
J Neurooncol; 2021 Jan; 151(2):157-171. PubMed ID: 33128099
[TBL] [Abstract][Full Text] [Related]
5. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
You S; Li W; Guan Y
Mol Med Rep; 2018 Mar; 17(3):4203-4212. PubMed ID: 29344654
[TBL] [Abstract][Full Text] [Related]
6. Human Umbilical Cord Mesenchymal Stem Cells-derived Exosomal lncRNA FAM99B Represses Hepatocellular Carcinoma Cell Malignancy.
Xu G; Ban K; Mu H; Wang B
Mol Biotechnol; 2024 Jun; 66(6):1389-1401. PubMed ID: 37351835
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding ribonucleic acid W5 inhibits progression and predicts favorable prognosis in hepatocellular carcinoma.
Lei GL; Fan HX; Wang C; Niu Y; Li TL; Yu LX; Hong ZX; Yan J; Wang XL; Zhang SG; Ren MJ; Yang PH
World J Gastroenterol; 2021 Jan; 27(1):55-68. PubMed ID: 33505150
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.
Li R; Zhang L; Jia L; Duan Y; Li Y; Bao L; Sha N
PLoS One; 2014; 9(6):e100893. PubMed ID: 24967732
[TBL] [Abstract][Full Text] [Related]
9. Design and Functional Validation of a Mutant Variant of the LncRNA
Battistelli C; Garbo S; Riccioni V; Montaldo C; Santangelo L; Vandelli A; Strippoli R; Tartaglia GG; Tripodi M; Cicchini C
Cancer Res; 2021 Jan; 81(1):103-113. PubMed ID: 33158813
[No Abstract] [Full Text] [Related]
10. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
Chen Y; Lin C; Liu Y; Jiang Y
Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
[TBL] [Abstract][Full Text] [Related]
11. Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis.
Su T; Zhang N; Wang T; Zeng J; Li W; Han L; Yang M
Cancer Res; 2023 Dec; 83(24):4080-4094. PubMed ID: 37756562
[TBL] [Abstract][Full Text] [Related]
12. Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells.
Kan G; Wang Z; Sheng C; Chen G; Yao C; Mao Y; Chen S
Adv Sci (Weinh); 2021 May; 8(10):2004344. PubMed ID: 34026451
[TBL] [Abstract][Full Text] [Related]
13. RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma.
Zhou J; Tu D; Peng R; Tang Y; Deng Q; Su B; Wang S; Tang H; Jin S; Jiang G; Wang Q; Jin X; Zhang C; Cao J; Bai D
Cell Commun Signal; 2023 Aug; 21(1):224. PubMed ID: 37626338
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity.
Fei M; Li X; Liang S; Zhou S; Wu H; Sun L; Liu Y; Hu Q; Liu L; Wang J
Cancer Lett; 2024 Mar; 584():216620. PubMed ID: 38218456
[TBL] [Abstract][Full Text] [Related]
15. HOXB8 Counteracts MAPK/ERK Oncogenic Signaling in a Chicken Embryo Model of Neoplasia.
Wilmerding A; Bouteille L; Rinaldi L; Caruso N; Graba Y; Delfini MC
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445617
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling.
Shah AD; Bouchard MJ; Shieh AC
PLoS One; 2015; 10(11):e0142337. PubMed ID: 26560447
[TBL] [Abstract][Full Text] [Related]
17. Combined VEGFR and MAPK pathway inhibition in angiosarcoma.
Wagner MJ; Lyons YA; Siedel JH; Dood R; Nagaraja AS; Haemmerle M; Mangala LS; Chanana P; Lazar AJ; Wang WL; Ravi V; Holland EC; Sood AK
Sci Rep; 2021 Apr; 11(1):9362. PubMed ID: 33931674
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-2 Facilitates Malignant Progression of Hepatocellular Carcinoma.
Hu X; Liu T; Li L; Gan H; Wang T; Pang P; Mao J
Turk J Gastroenterol; 2023 Jun; 34(6):635-644. PubMed ID: 37162505
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells.
Wang R; Li Y; Chen Y; Wang L; Wu Q; Guo Y; Li Y; Liu J; Wang L
Oncol Rep; 2018 Sep; 40(3):1233-1242. PubMed ID: 29956808
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel ferroptosis-correlative lncRNA signature and validation of ST3GAL4-AS1 for predicting overall survival of hepatocellular carcinoma.
Xuan Z; Liu L; Huang P; Ye Q
Asian J Surg; 2024 May; 47(5):2524-2526. PubMed ID: 38378408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
